DIRECTORY
BIOTECH
Pharmaclient

   

Quick Click ! Monthly news Home-Site Contactexpress Faqs Legends Search Companies Events Environment Memories Home-Biotech

AbAg | Abcys | AB Science | Adocia | Advicenne Pharma | Affichem | Agate Bioservices | Aisa Therapeutics | Alfact Innovation | AliX | Alizé Pharma | Alphelys | Ambiotis | Anaconda Pharma | Aptys Pharmaceuticals | Ariana Pharmaceuticals | Atlantic Bone Screen | Aureus Pharma | B Cell Design | BioAlliance Pharma | Biocortech | BioCydex | BioMedical Diagnostics | Biométhodes | Biom'up | BioProtein Technologies | BioQuanta | BioSystems International | BMSystems (Bio-modeling) | BT Pharma | Cellectis | Cellial Technologies | CellVax | CellVir | Cerenis Therapeutics | Cezanne | CliniGenetics | Covalab | Cytheris | Cytomics | DBV Technologies | Diatos | DNA Therapeutics | Domain Therapeutics | Dynabio | Endotis Pharma | Epixis | ERYtech Pharma | Exonhit | Eye Tech Care | Flamel Technologies | Fluofarma | Fovea Pharmaceuticals | GemacBio | Genepep | Genewave | Genfit | GenOdyssee | Genomic Vision | GenoSafe | GenoScience Pharma | Genoscreen | GenOway | GTP Technology | Helios Biosciences | Hybrigenics | Hyphen BioMed | Imagene | ImmunId | Immutep | Imstar | In-Cell-Art | Indicia Biotechnology | Innate Pharma | InnaVirVax | IntegraGen | Ipsogen | I-Stem | Ivagen | Karcinolys | Keosys | LibraGen | Magnisense | Mapreg | MAT Biopharma | Mauna Kea Technologies | Medesis Pharma | Mellitech | Meristem Therapeutics | MicroBioChips | MilleGen | MitoProd | Murigenetics | Mutabilis | Myosix | NanoBiotix | Nautilus Biotech | Neorphys | Neovacs | Netris-Pharma | Neuronax | NicOx | Nokad | Nova Decision | Novagali | Novexel | NovoCIB | Novotec | ObeTherapy | Oligovax | Oncodesign | Oroxcell | Oxincell | Palumed | PharmaLeads | Pharmaxon | Pharnext | PhenoPro | Pherecydes Pharma | PolyIntell | PraXcell | Proteogenix | Protéus | Protexel | PX’Therapeutics | Quantum Genomics | Rhenovia Pharma | ScarCell Therapeutics | Sepal Pharma | Serial Genetics | ShigaMediX | Sisène Biotechnologies | Skuld-Tech | Synapcell | Synprosis | Tc Land Expression | Theraclion | Theraptosis | TheraVectys | Transgene | Trophos | TxCell | UroGene | UROsphere | Urrma | Vaxon Biotech | Vectalys | VigiCell | Vivalis | XenTech |

* BT PHARMA *


2001 - Midi-Pyrénées
Labège
(near Toulouse)
www.btpharma.com

Discovery, Immunology
Key words: Therapeutic vaccines, HPV, Cancer, Viral and bacterial infections, ProCervix
Mission: to develop immuno-therapeutic products for the treatment of infection, neoplasia and cervical cancer, caused by Human Papillomavirus (HPV)
Clients: Prescribers
business@btpharma.com

Identity
TYPE/MANAGEMENT/INVESTORSFINANCES/STATUS

Spin-off |
Managing Dir.: Timmerman (Ben) [founder, Ph.D. Molecular Genetics, MBA, ex-Novartis Agro, Procordia]
Sc.Dir.: Préville (Xavier) [Ph.D. Life Sciences, Gercor, Sangstat]
Fin.Dir.: Koch (Martin) [Eng., MBA, ex-Eli Lilly, Cap Gemini, Elan, Zeneus, Cephalon]
BusDev:
Financers: Institut Pasteur, FAM-Midi-Pyrénées, Edmond de Rothschild Investment Partners

Turnover (M€) : 0.36 (2006)
Total funding (M€) : 9.0
Last funding (M€) : 2.8
Focus : Vaccines
Position : Preclin
Company confirm : neutral

History
DATEMILESTONETYPETIME
2008 .09 2nd round-financing : 2.8 M€ mainly by Edmond de Rothschild Investment Partners RFINB [7 years]
2007 .09 Clinical trial (phase I) for Procervix, HPV vaccine (beginning) CLIN [6 years]
2007 .05 1st round-financing : 1.3 M€, mainly by Institut Pasteur and an undisclosed private investor RFINA [6 years]
2001 .10 Company founded by Benedikt Timmerman, as a spin-off from Institut Pasteur (Paris) ORGF [0 year]

Actualisation / Updating: 31-Oct-2008


Pharmaclient est le site-conseil de la Valorisation Client en Pharma...
Pour toute Mission, Inscription à la Pharmagalerie, Insertion dans la base Biotech, ou Question: CONTACT
Pour retourner à la page d'accueil Biotech: BIENVENUE !

Haut de page :

Copyright J.H. Huber, Pharmaclient 2001-2008.

Pharmaclient, le site de la valorisation client en Pharma, est la vitrine des activités de conseil de Jean Huber: Stratégie, Communication, Relation Client en Pharma.